0001193125-13-402483.txt : 20131204 0001193125-13-402483.hdr.sgml : 20131204 20131017162033 ACCESSION NUMBER: 0001193125-13-402483 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20131017 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Crestview Acquisition Corp. CENTRAL INDEX KEY: 0001587350 IRS NUMBER: 463671375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 401 CONGRESS AVENUE, SUITE 3100 CITY: AUSTIN STATE: TX ZIP: 78701 BUSINESS PHONE: 512-730-2400 MAIL ADDRESS: STREET 1: 401 CONGRESS AVENUE, SUITE 3100 CITY: AUSTIN STATE: TX ZIP: 78701 CORRESP 1 filename1.htm CORRESP

LOGO

 

 

601 Lexington Avenue

New York, New York 10022

  

Daniel Wolf

To Call Writer Directly:

(212) 446-4884

daniel.wolf@kirkland.com

  

(212) 446-4800

 

www.kirkland.com

  

Facsimile:

(212) 446-4900

October 17, 2013

VIA EDGAR SUBMISSION

David L. Orlic, Esq.

Special Counsel

Securities and Exchange Commission

Division of Corporation Finance, Office of

Mergers & Acquisitions

100 F Street, NE

Washington, DC 20549-3628

 

  Re: Greenway Medical Technologies, Inc.

Schedule TO-T filed by Crestview Acquisition Corp., VCG Holdings,

LLC, Vista Equity Partners Fund IV, L.P., and Vitera Healthcare

Solutions, LLC

Filed on October 4, 2013, amended on October 8, 2013, October 11, 2013

and October 15, 2013

File No. 005-86773

Dear Mr. Orlic:

On behalf of our clients, Crestview Acquisition Corp. (“Purchaser”), VCG Holdings, LLC (“Parent”), Vitera Healthcare Solutions, LLC (“Vitera”), and Vista Equity Partners Fund IV, L.P. (“Vista” and together with Purchaser, Parent and Vitera, the “Filing Persons”), we are submitting this letter in response to the comments of the staff (the “Staff”) of the United States Securities and Exchange Commission (the “Commission”) in a letter dated October 16, 2013 (the “Comment Letter”), with respect to the Filing Persons’ Amendment No. 3 to Schedule TO-T filed with the Commission on October 15, 2013 (as amended, the “Schedule TO”), relating to Purchaser’s tender offer for all of the outstanding shares of common stock of Greenway Medical Technologies, Inc. (“Greenway”). The responses below correspond to the captions and numbers of those comments in your letter (which are reproduced below in italics). In addition, the Filing Persons are simultaneously filing Amendment No. 4 to the Schedule TO (“Amendment No. 4”) in response to the Comment Letter. Unless explicitly set forth herein, capitalized terms shall have the meanings ascribed to them in the Schedule TO.

LOGO

Securities and Exchange Commission

October 17, 2013

Page 2

 

The Merger Agreement, page 33

 

1. Disclosure has been retained to the effect that the merger agreement has been provided solely to inform investors of its terms, and that the company’s stockholders and other investors are not third-party beneficiaries under the merger agreement. Please revise, as requested, to remove any potential implication that the merger agreement does not constitute public disclosure under the federal securities laws.

Response:

In response to the Staff’s comment, Amendment No. 4 amends this Section in accordance with the Staff’s comment.

*     *     *     *     *

 

LOGO

Securities and Exchange Commission

October 17, 2013

Page 3

 

Please do not hesitate to contact the undersigned at the number above with any questions or comments you may have regarding this letter or the Schedule TO.

 

Sincerely,
/s/ Daniel Wolf
Daniel Wolf

 

cc: Crestview Acquisition Corp.

VCG Holdings, LLC

Vitera Healthcare Solutions, LLC

Vista Equity Partners Fund IV, L.P.

 

 GRAPHIC 2 g613921g55h65.jpg GRAPHIC begin 644 g613921g55h65.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`+@#V`P$1``(1`0,1`?_$`'H```(#`0$!``,````` M```````)!P@*!@0%`0(#`0$`````````````````````$```!@(`!`4"!0(% M`P4````"`P0%!@W.1H1 M`0````````````````````#_V@`,`P$``A$#$0`_`-_'`'`'`'`'`'`'`'`' M`'`'`'`'`'`'`'`'`'`'`'`'`'`'`'`'`'`'`'`'`'`'`)9[^^YFQ>@/;HF^ MU&L,DBT?L:O[$J]N4$S*'HIFQ/L55KDH@Q1\ M_N*>Q\A:GQ"Q*96K";'F\D_(EN$YB3/B,](,P.GVEW8W'J;O==NG0B#V=#AT M#LE3LAL&VB'BL6%1,#E]7-UE.+_[>D@59?2B)S[.2%C*P0/+?YAHB!9\0!`% M4Q;>=Y'87NZ;^Z':M;':IU[!-3V:%6+%#[JH!TDY[S'K#9(D[M<-P$'A-*[K:16;)*!M%]K M7U$CJ-TF/HY.W1N>Q!`_K')3A,G?XLMRI;5*E24,L@HS!F`J,D$`N'3?O=7\ MZ]E38S?+:^R8HZ[$J;MLO6_5N'UO5;2@.E-SIH['6FI(;'804L<%,Y=)#-WD MQ9[3E2>/_%.&(+J86<\0I`])1*W8I0+SW-*>`O&4PP9P&A#7QXE\BH:EI#8# MVEDD[D%55^_3)^0M:=C0.\H>8JU.;ZO0,R3Q3M:%0YJC1$IPY%Y160AR(6<9 MSD%&=]'>7:C4>J*!@FA9;-(=R]@+2E*2`0%ZBK1,$3]5M2U;,+)N9\4MCFK1 M#2EQ=L;F\8#RC,"R3V57J5/8Z)CP` M*./6S&#E,4LAL2(SLJ!(TR68-"HU*2=S9PD,)SGFP+&<@@7M/_<#VU9>]US: M(=PI1%&H<@NFU*QT^OUJA6*VBEBR2I)X[P5[K)[#E8I8E,F?O1ICVTY.8'.' M`8D!N!&JD6,@X?N!;*;)4INEVJ*DIV>1B,UAM??UBUC>#,^05MDSRY,,)K_% MH(AQ1\5'DG1Q"QA!^<> M`!<[6SNF[;T?NK`.W)W=:DJ6N;NY9W--N(+OI<.G]*;':[:,Q'77 M2%QW&)LG82LB[%5;.O3:8J4+:UAYC[)(VQ1Z.-B-$8G4'H`K'L2M.IR06;@O MRRP=5VW=GIGNAHIJ[M-8D&)KB;7=5#%-9)$4@%Q;8B<58U20QR8BW,1K@"-R M0M&%S;,'&&F8;UA/B89G]007;X#(M1>UG?'W4WD[E^N>N6TFH%<5_HQ?+A6S M.Y6[KRY/X M+VZ^T+`=FFZ=U`3MY7SS2<9OI8B@I,JJJ:/4P\R*S02R"E*A?YF]%2.7OU8P1[E#^0U)6-.\R!VB[6X/#D MG940S$C2G6."@P9:8L0PD@S@&!"\.;()4T(WCVRO#O#]T336UY_$'RB-.TL( M5U6SLM=-$?DRH-J],D32"3RE.J.4N68V.;3)!#'5L5MRU2D&D-*ZX6K* M4%&?:[?>EMI[#VKFT*ECS4^UDSH"&$PBOD$"0D,=>LC& MK6/;B4D6KS5SE(5L@QG()")4%3A2E/0^KY>1:(.P^["_\`I0V# M_P#<77[_`.88IP"X-&+-DO:8[NI\.W!4ES>H>[M5%%/>MNYLU3(B9/%Y7&86 MPMC%K?)9"6`AL9HBRKG8AD)1$X)**R%A5BQ@M0;Z<+E;RXSG[HWL\^&,Y\-5 M=BLY_P!/;=Y_CP%`I7"]R)WWEON'6?02TQ5+M2DUDUT>ZU>@,L;>3)&8T1:J MU3S`41LH;W%!'WJ8M.#4K:Z@"$Q`Y9('D82_,S@&^?;BRO427]OIR<=>8H_P MN]P3:0)]\V2RY$Y2N\U&V)1!A,ZD5H/KZ!.^.!61D<=@M<=%>X-L0VWQK:Z($[HRP9HGJN"MAFQD-0 M!`4`$U:RG(I&%Q69.PU.2-H/!Y:?U8@AJ1^YCN2M]A?M^9I>-/RENFM8VI(] M8YK"9.UF8,2.S"^6C%E:0W(?^XE6$<^2E*#518C)5BJ5H&N0GQ2.J'!B(((4D`4$J$R[GP+(!F9"$M6.UW7?=-[8>\- M6NB\,'O.N^Z_OY/=9;H1^:G>:QM-#.V@YMP8X(\8J2)Q!"$-=.X_:VTVYO9STYW19G6&=Q+1+=Z[*UV$97E$84;84<)U@G+;$ M;B2+B09;5BJ1%I<%N(R1Y)6'Y*<4WBE<"@E@R'LH8S_,W]Q5GPSX8V%I;&<_ MX8SD^X_#'C_GGPS_`-.`YKO^N3;?7<.['NH-0C(DNRD>W)9-BWY`RC-4/%:4 MC$'F(.4476+`",Y/-+81Y_IR410@^F3J MR\I@>8E5A7`ZWM(]UE[M&7R;MJ;[1>(:X=RG6,E##7VN&T3.RP2\H>T,:)5' M[#I4AM-"QC"NBHTRY0S-_@4!"<6L0EA1C&0B#0-P&&S0W1^7;@=V#OS.$0W4 MV[U#<*YW+CQF,:RSQJB3'.A/$AM14`NQVIR8G04C*:L,F2T@"STOEEJU&,YS MSX\`9=]V<(&.RQ<:7U(%*A';.O!:K/.')V!"L1JY3#R\"$(H1^,QG/A^&,YAC5G&,Y_SSC&?#_3@)<^["-*%V4M MB2`FEY/*L'70TPG`PY-+*.NN)@)-&7C/.`LT9`\!%G'@+(!8Q_3/`2%L%V;M M8>Z1I_IG*)C()E2^R]/ZX4BCJ/9FGW7I=CU^8"OHN_HV9U3@4)B9"P)UZSUI M24PU(M2F*!&HU:41Q@C`J+VS-N.Y'J'W/@]E_N*V?&]M$4FHQUN?739UI)-) MG@XK'P/:I.DL4XXHEP<4SHAC#FE,RZ^I=4;FD)QAPL$@P!P@=S M&)D#P4()F0'!?JPYB18!G.0FA\<>(<_CCQX#4^8<43@&3C2RL&&`)+R8,(,# M-,SREE`YLXYC#!?@$./QSG^G`8R?M]:RN6VZ6[P,$I;8%9K5(7[N=WDV.-FL M==L=@S%H:EK4C3*3(63)G9$P1Z2DA'D29P4I'(*8?@,*?(PA%@':Q[LDZ?Q3 MMH3OM?QU?:334UFKT,PGMJI)80&[Y1;K;.(C92"W7.6":Q-YLJ2S.!M!P"L( M@H\(T):7RO+\[?E9]S36IRU7N.>69`ZV?9;%I;(E-5+HNVR)[,AZP MQU9F=2NE47EB,EI"\X(5F8*3@.&8E+QYF`:68ER6 M+``A!I?9UK]?M/I;N)-]I=HK'NG1RN"ZKK=YE[O59Y,XBAA6[0%JW["WN(7_`!*MGN,XJ.XUKHWF)6Z?2N!R6*/Q*6QHZXCP MX)71O4(Q#6^:8>6;ZI;ZD/SH1VI=>M!-5+(TSBT@GUX45:?D36$1A*DDXP)AIF0F8P+&,!3]S^WCU?4:8VEV M^&C83;)DU&L>VH_;K35>9K7LA^*G)C=E$A.BE9R645D\/[5"'N1"3KU:-8(M&HJB>%*EZ4FC">:ERHP6()>1B` M6#`0A^[.V%6ER[_T5W'2;@N6M+VH.!BK./-=?*(`C@\M@ZQ;*%3W'K$;GN"O M;Y)T#V1+U9`P=0(].#!8T_E&EA,X"3M#=$X-H%7MGUS7UCV99#3:MYV%L&_. M%H'0]4[HIY:1Z%=,P-:B(1.))P,K@YH<*2R#BCAD&&#P$SES@.`C:].U7K%> M.]FLW<75(7B%;,:VKUP026)";4[=:\8416119OC5FH%:%0)SS&B9$:8VN"M;&@;:UU2:8>TQHIQ-3MWJ35"E,4,7@;D8QB$%WM'^U)J)H1)IQ9M5,L\ ML&_+/*PFL?9._I^]W!?$R0X]((36OG4C%S-S2::A*,.3-Z=&6I&46(_!N2BL M@!DO`(WV![&U:S_:R>;G:O[8;4:"WG%O MMQZ*W0=[6=`(^HSN17,I3*Q/:LXUM3")0G(7)Y3H3 M6^,UBF&I:8^8ZFDMY:DQ08G(SG'/G(A"$$I3[L):YV9H>Z:"S387;23P:7WF M'8&T+?E-B1277W:TU3%8(:4LVG4I@CPD6,+,0D0@3D$H23`X;BU(K2U74=*I!4LOBHHG;4?J* M/$16)2BR*W/CJ"+NT[`P)"4QRXD)"?)9!>`)P>&>8)[T5[3-(Z4V9/MC7>R[ MJVLV\M)D*B\YVEV8EY<""$P`@9SCP M%C./''`9JZ^^V:IZH03,BG.Y-W5:<;[#E3O.)JRU-LI%ZZ8)'+7X61.T@<62 M*5',>F;],IS7 MUA0RQ(BFN"5VE.GM-(WRU9[8CU`'IX<9R%Z)&H3*T7H,)S#LY"'\A7($AZS] MEJ&:\[`078J4[T]P_:B4UBWRLNOHKM9L.5:]>Q:02M@6QDZ8HHL9$VD@Z1M3 M0YJ0(S#3!EDC.R/DR,(,A"<>VWVNZC[9#3?#+4-H7#8R+86T3+DFN;<<(4YJ M4D^7)CDCVZ,BB(PN'B((?"A$^>2?Z@(1)P9+R#Q'S`S+@#@#@#@#@#@#@#@% M)7YW&GJHNXG1FJB-C:55-2UO;81<-@*898BY9!KNMQHE#Q03*1.FY(&K65O7 M"AY")U;W964YGGR]D&D#D`C?$%ZX[U>RR+75.HF]:U-76VT5[%A7(Z[4Q2D]P]-M56I4JI&5,C)*2]@IMJY')V_HYOF[G08II&D5RNYG0A M,Y1+=C+<,:Q9X'@&$SE;WV\DH+4.UGA'6R9SN_N!2?62PS36IX0,#-5#!;FQ M,&&_L^%$H&8UR5-'ZD;U)ZQ4>H1!-,4"RG"`0`EA1M/W>=GK+H'9ZRJ\;JFK M>:4S=U'OM=1^T*1N<)=B:?[5VK&*JI64FMLFE]7NIDWCCFM=Q/;LU]0CJY0W MDD)/+P<(P(2O:7<(W1JE+W1#EA%6R`&A,)A3=#)""BI@TU[/K(DU04%8JM8^ MROYU<5B!2B<;/7X]KD(,&Y:\I#L.XC`&@&%V*QVBO9LFV[-%7#BK9G8FJ]10 M"Y(U9]8QZ1Q6&REEM*)6.[,L2G,%>Y9,5\.GD9>:U4F*$Y+VI+<6-P0K`83" M-$7@%=OG=KWQK;4F(W3+J@KB=32UX[KS:M-G1&EKO0MR9=0UU-X?,:.HNE)/7=>F69$6E MQL:P3Y^7"9#,NN29*$D"D49`H&C)R>B_/Z32# M:DO*\U*$2

3A" M#L5._P!OG+)^RQ&EH+3\^?TJW8EP5UWBO9P)?.V:H=_ENK38UD3DFR4K+5!" M2J4QKVZ2!T2N*$MR29P!-R'`39"VFBNU%YVO;5V4SM6)KK*_(4D'+2M<_B-^ MB86"MS9Y*8M&[,K.ZCYQ*XKL95$K1($9/5T*9K6MSN6<0M1I!F%I@`T3@#@# M@#@#@#@#@#@#@#@#@#@#@#@*56;]#?L&^?E/XO\`87SK7_S[U_U'IOJ"]54? MQA[C\/W_`+\]7[+Z+Y'ZO/T[T_\`X^`B>S_XLOC.KOE?ZVXC\P=`\W^Z_#WMKHG5_']CY?I>?\`-ROGS' M\)?.?H*K^G7KOA[IZ=[])^&O:7IOR>F^1?#H/F?AU'G]/^?GX#I)']!G1[A] MS_$G1?JMJWYGZAS>E^K_`*G4'Q'[CYO_`%0ZO[*Z5R_J>=T_D_-RLZUZ#Y.ZE:/7?)]3^TZ_UGW9Z_T'X^J]9Y_ZGCP%L+S_ M`(YNM)/GGX1ZU\*5OZ;W/R>;\$?.$&^*>?T_Z7LSY]Z#T;S/R=<\GR?S^/`0 M+>/\-?S#LA\^?3I\N^W5GU0^\>H^IZ'\<1WU/R5S?V/U'Q7TSE\[]UT;R>3] M'PX"TNM?T)_!]A_3%\._"OJ9+\N^R_3^3U/VZ3[E^4/4?\EZY[1\CS.L?N^F M>1R?M_*X#I*E^C_FHGX>^.?#Z83OI[]N<_I_I5\ZN_4^P^;]M\?^9[7\WRO] MOH>;\OE\!62BOXE.C0OX"^G'I?SI5'QU[2Y/4?/OPZ1\2>R/,_N/N[Z?^3T/ MH/P]G>/-_;?'@)]I[Z'?1T+\,_%/3_C^\_I^]O>/HOCCW;&?G_VIY_[?V_[P MZ3UOG_)ZGR.;_;P%+VW^#WW'4W0OI7ZO\1M_Q'[=\WI'P?[NM#H/1>C?\<^. M?>?NSIGF_L/6>L]+^;QX#TV?_"QTBN/>GP1Z/X9ISV'[)]W]8^`_9LB^%O7_ M`!?_`'_XQ^.>I].ZI_;N@>=S_LO'@+"%_P`9GQM<'3_IX^)_?^N/S#[?Z9[( M]_\`1J;^EWJO0_[1ZOH7L;VMZ;]#T_3/(_+Y7`=Q1OT)?*XO@7XG^7O:UZ\W MM7G]Q^TOJ%6?4%_W?PZ9]2?G=<_PZ_S<_P";@.;TR_C[]RV3]'7L/WEZ-I]] M],]U^Z_:G57KV[TGW[_>OBOKG4.F]'_XUZSS_3_J^9P#`.`.`.`.`.`.`.`_ "_]D_ ` end GRAPHIC 3 g613921g92k82.jpg GRAPHIC begin 644 g613921g92k82.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`'`#4`P$1``(1`0,1`?_$`&X``0`!!0$!```````` M```````*!`8'"`D%`P$!`````````````````````!````8"`@$$`@$`"P`` M`````@,$!08'`0@`"1$2$Q0*(3$5\$%QD2(C)"46%Q@1`0`````````````` M``````#_V@`,`P$``A$#$0`_`)_'`?Z?V?O^[@.`X'P- M5)B#$Y)R@@DY4,1:4HTTLLQ28`&3!EIP#%@1PP%AR+.`XSG`<>?UP/OP'`?6%+DSWQ`\?GS@/C@5O`@/ULKEJ*OII)9?+XBII2P MY3>!TC>0RZP[>D=R5V3+;&+>"70Y6W('A.XG)$"$@_*5(S9*2A]8<"$,,5=C M[5J.S=LNF[IN:UO:K5"#]0\WLJU&-D6VR)N*+KR3N39&Y"JCU2N2:1.!\<3N MXRRS2RQX)+%@PT6`$A&6%UZ]P>^V?H([7I=/GRS"]8;(A6T%Q]<44MBP5DWN M.M=3U$$6R:GAODN_FWUZ:0&*T:=R9T"ES4KFX`?6,0,FX!@,?]6,A8.TF;Z* M:T3!Z7PVD.IK5+6&ZYA5TB7NK%9^UVS5G5DTK&:?K$:A04[O.MU9X4_+-5B- M,+DC\Y$"4A-1G%>0Z0:P%8S]D[LS)R:J$E;])]6W%`A&N6F-J%PD!<8)>UZ) ML&H$WI%KJ4R)0GFEE!,,P3CSG_$+U!MGWB[7(M4^N^VE"68QB"V!L,MCVI]4 MR:8.J9DCD6L-R(IVW6)F;4)<+*R&2A@-D#:N7)#EM96$:%.O M*"+_`"U;R/&,>C`?(--4T]CD;2)G(97ME%B(QC(,*$R0M>'K=O:Y..$?9+E47 M?5H0-\\Z:9-!Y#'),Y@)0$S5GC@W%XB+DUN6"42*6MKP88>8B&`E!V:GKN)BFRZ$S&)RYJ;U2?.%"4`B%)P#,B$7@90P[;Z%;(+]P-+-7=H7=A3Q=YO6D M:^LA\CZ,T9R!I?I%'T:M\1MIAHAG";"W;)WQOO.1><\"%YWM6>B4 M=E^Q$>;7LJUH\94FH->.&T@U=R9C'2-8KG:9(3K)4.M;(5K(TO-C,Q@GM2$L M](YY/&20H,^,$Q,>$\^"N#<[0J(N;1+4<]:U\98E3?.&Y8WN""8HSFQ,-/*$ M:YJ-.;%:=^+SA4`Q.,1`PF^09R'.,\".;]I0AG)T@UJ>7=KESNE2=@>M;.[- ME?JY`DF\AA\F!-6R9PV.AC#HSO+BMES+C*4I(4H+&>I]GT"":$L80R7"J=U" MB'59V.V!J=K5L9JPRS_7W8-IF=;;)I+HBM@`D]6U%-BFB2H8E;LWF+Q&TA@7 MKW$JYN4)R5N2@&^,C*"/`;*=!BA0MZ=]!G%:I4KG%UI).Z.;@N4GK%SBY+Y1 M(U*UYT/IF4 MYB-IOO2.N7U(]N:YQ.C<2NY_L9/"HC8"AGR:>WEK6S*9"4:H`G$;\4G(?`L9 M%@0[J1)TY7I**]X6`XQ MCQC`4KTD"F^T]"TY*APPA<^HQ^F"QJ$Y+A,XY4BOPV'IY$!HR?\`QQ;R&+BR MARHP7[N4^?1D7CQC@>']D2+,DW9NJ2$R3#F.,6)VJZ[UA.$C1(I!%E+[7D\; MY0US.+*GF,.C.\D-;\WE!"?@E06/&2P#`((P!%@+R!3&O2UD-/:B"ODDB M.P,P)7`D]\!P.#[IU42:Z.Q/LLM[9:-U7,--=Z=6:AU[1Q5OE3XKLU*MK)L8 M$PI`Z,RN&I&*/K0.I:EI6_R&P0/* MQ_`@BZJ`XC,BA!8U)+>9A8N3&K$YQQ@B`XP$H0:ZM/51N50.L?8SU\T#/:EL M'279&JK92:9,]IR^9,-@:IS&X6Y8V2:HW!,:J97$3.<>VF*A@R3ZP)U"8+ADVHG:_6?:%LEV`ZSP M+1J11_8NA:-J!Q@-X7=C$$.CSX M;&++AH0R2/5]1"16B2N2Q8!;_.O*LXI*22$K@>QL_P!>]J)>P_1'>_2B,4G# M5M+,]J5#M)$GES4ULEM6@;%"T&(&=D30^!OR5TEL/?!KG9!E<-*F^66G",>0 M_D`7;H/UW.-:]>MAZ0[G16LK"8+-L_:)YF$;C+TZRN(OL!OJWYE9C4D-7O,; MBCBAD#,FEH2LF$D8&D7(P*4Y_KP`0`X6*OKH[D5WIUVBZ9U?UFUZ@^%EW@4132S0[FU56,(I2LJ^I^M&--&:]JZ&1J`0F/I/ M5E.S1:)-"1C8V\`QYR8;E,W(2PB,'G(S!8R(6Q/4?8'L"(UB MK/2K;S5SL?ME\N67LNU4SFT"D=52N;M"EIFD8FS6P06JH0%HL)&\@255 M\8.2_)(S#!C"_NNSKT[).KQUAE0P"^:.VJTJD7^\S>J+"Q.JFFNM\S?5)BZ4 MI]7'33 MFKML:>V-6K+JE4JC$6-0T]A_"=P&Q%4;1U/LI$="*ZA]CZHW'5]=,M(6-=DP>I)I4'%M[6YKU1Q@`^K``9P(->.O37;NUU!H;5+3EUCW7"@I.E11:% MS6X&BQ]@)I:JNK4,A,=9,HC%?N%:PZ'FSM(&`YX&:6G1#L+;>Q^S]]2Y7K,3,Y9U=Q_55@?@K9N M2V1L365JS^[K#1((;(&]Z)4M-2M:,E"G,5J1 M^!J50R2,9,,S^1CSG.?WP(U&M&H'=7I+9F_<@H"!]<4WBNXVXEP[4L)MNW9L M(WR"%'V$N)(9V)U00ZFOX]W3H69N3C4%E*2!_)&9@)^08#G@7E<.E';(V=F5 M4]B-)H]'K(DD7T'BVIE@L5LV#<%;M4@FCE,S;(LN715OA=:34]D8B9*(*1F* M4JE)N46!"/#[GC/`]G;G2/M!W9KC1EZN;_QNS73K9V15MMM*8Q6\SM1OK)JI M6J"Q)F:#1F12.".THF-AR(2U4K5+%B5J0D&#"4`'H#YX$B/@.`X#@.`X#@.` =X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.!__]D_ ` end